Watchdog Asks Court To Reject BioXcel Ch. 11 Plan Releases
The U.S. Trustee's Office is urging a Delaware bankruptcy judge to reject AI-bolstered pharmaceutical group BioXcel's Chapter 11 plan disclosure statement ahead of a hearing Wednesday, arguing the plan contains nonconsensual third-party...To view the full article, register now.
Already a subscriber? Click here to view full article